• Daily Marijuana Observer Facebook
  • Daily Marijuana Observer Twitter
  • Daily Marijuana Observer StockTwits
  • Daily Marijuana Observer SA
  • Daily Marijuana Observer Instagram
  • Daily Marijuana Observer Youtube
  • Pinterest Social Icon
  • Daily Marijuana Observer Talk Market

Cannabis Company Begins Sales, Projects $2.8M by End of '17

July 6, 2017

 

There are so many cannabis-related companies still in the development phase, yet some market caps are through the roof! Finally, another cannabis company began achieving revenues. GB Sciences, Inc. (OTC:GBLX) has been using the last year or more constructing what is striving to be 'the cleanest grow facility in the business'.

 

Beyond the existing Las Vegas, Nevada facility that GBLX has in place, the company is expanding.

 

Kevin Kuethe, VP Operations for GB Sciences says that "within the next six months, we expect to complete the Phase II expansion of the facility from 200 lights to over 600 lights," which is estimated to triple the company's production and increase their harvesting frequency tremendously. 

 

First Harvest for GB Sciences

 

GB Sciences just announced that the company harvested its first cannabis crop, and sold 63 pounds of their premium flower. GB Sciences, Inc. held back an additional 66.5 pounds for converting it into medical grade oil.

 

 (Photo Credit - Andres Rodriguez)

 

According to GB Sciences, the medical grade cannabis oils are "for scientific research and medical use." Cannabis oils tend to have far higher margins than standard dried flower. Since high quality oils can be made from trim and parts leftover from premium buds, there is less waste and therefore higher margins. 

 

We recently saw this phenomenon as cannabis oils pushed out record revenues at Aurora Cannabis Inc. (TSXV:ACB) (OTC:ACBFF), a Canadian licensed producer of medical marijauna.

 

Financial Projections for GB Sciences

 

 

Based on GB Sciences' conservative financial estimates and production rate, the company is projecting revenues of $2.8 million through December 31, 2017, and expects to complete its full fiscal year projections within the next few months. If achieved, that would be quite early due to GBLX's fiscal year ending on March 31, 2018.

 

This would be good for GBLX, since as of the period ending December 31, 2016, there was just over $1.2 million in current liabilities on the company's balance sheet

 

For more information and stock charts for GBLX, be sure to check out the company's stock profile in our marijuana stock database. For more OTC-listed marijuana stocks, be sure to check out our marijuana stocks organized by exchange. Be sure to subscribe to one or more of our free newsletters so you never miss an important cannabis investment update. Also, don't forget to connect with The Daily Marijuana Observer on social media via Facebook, Twitter, and Instagram

Please reload

LATEST NEWS
Please reload

Please reload

DMO

© Copyright 2016-2020 Smoke Show Ventures, Inc.

RSS Feed

Disclaimer: Except for the historical information and data presented herein, matters discussed in articles on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future performance or achievements expressed or implied by such coverage. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. Smoke Show Ventures, Inc. or its affiliates, which owns The Daily Marijuana Observer, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.dailymarijuanaobserver.com/legal-disclaimer/.